Memo - Magazine of European Medical Oncology
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
- PublisherSPRINGER WIEN
- LanguageEnglish
- FrequencyQuarterly
- LanguageEnglish
- FrequencyQuarterly
- Publication Start Year2008
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 44% |
| 4-6 | 48% |
| 7-9 | 8% |
| >9 | 0% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Memo - Magazine of European Medical Oncology been publishing? 
The Memo - Magazine of European Medical Oncology has been publishing since 2008 till date.
How frequently is the Memo - Magazine of European Medical Oncology published?
Memo - Magazine of European Medical Oncology is published Quarterly.
Who is the publisher of Memo - Magazine of European Medical Oncology?
The publisher of Memo - Magazine of European Medical Oncology is SPRINGER WIEN.
How can I view the journal metrics of Memo - Magazine of European Medical Oncology on editage?
For the Memo - Magazine of European Medical Oncology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Memo - Magazine of European Medical Oncology?
The eISSN number is 1865-5076 and pISSN number is 1865-5041 for Memo - Magazine of European Medical Oncology.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Lung cancer, Immunotherapy, Breast cancer, Ovarian cancer, Overall survival, Nervous system, Pembrolizumab, Diffuse large B-cell lymphoma, Hepatocellular carcinoma, Pathophysiology, Triple-negative breast cancer, Chimeric antigen receptor, Metastatic breast cancer, Esophageal cancer, Colorectal cancer, Atezolizumab, Amyloidosis, Lung cancer screening, Intraperitoneal chemotherapy.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.